• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭进展过程中的细胞外基质概况。欧洲青年生理学家研讨会主题演讲——2007年布拉迪斯拉发

Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007.

作者信息

Graham H K, Horn M, Trafford A W

机构信息

Unit of Cardiac Physiology, University of Manchester, Manchester, UK.

出版信息

Acta Physiol (Oxf). 2008 Sep;194(1):3-21. doi: 10.1111/j.1748-1716.2008.01881.x. Epub 2008 Jun 28.

DOI:10.1111/j.1748-1716.2008.01881.x
PMID:18577182
Abstract

The myocardial extracellular matrix (ECM), which preserves the geometry and integrity of the myocardium, is a dynamic structure whose component proteins are maintained by a finely controlled homeostatic balance between deposition and degradation. One of the key targets in cardiology is the elucidation of the molecular mechanisms which mediate pathological remodelling of this matrix causing the transition from compensatory hypertrophy to congestive decompensated heart failure. In response to injury or increased workload, cardiac remodelling including myocyte hypertrophy, develops as the heart attempts to compensate for increased wall stresses. Persistence of these stresses over extended time periods leads to disruption of ECM homeostasis resulting in irreversible maladaptive cardiac remodelling, ventricular dilatation and finally heart failure. ECM remodelling is regulated by the matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs). Clinical studies and experimental models of cardiac disease states have reported alterations in the balance between the MMPs and TIMPs in the failing heart and crucially at intermediate time points in the progression to failure. This article reviews the recent clinical, genetic and experimental approaches employed to compare ECM, MMP and TIMP profiles in healthy, compensated and failing hearts and identifies common themes in the perturbation of ECM homeostasis in the transition to heart failure.

摘要

心肌细胞外基质(ECM)维持着心肌的几何形状和完整性,是一种动态结构,其组成蛋白通过沉积和降解之间精细调控的稳态平衡得以维持。心脏病学的关键目标之一是阐明介导这种基质病理重塑的分子机制,这种重塑会导致从代偿性肥大转变为充血性失代偿心力衰竭。作为对损伤或工作量增加的反应,包括心肌细胞肥大在内的心脏重塑会在心脏试图补偿增加的壁应力时发生。这些应力在较长时间内持续存在会导致ECM稳态破坏,从而导致不可逆的适应性不良心脏重塑、心室扩张,最终导致心力衰竭。ECM重塑受基质金属蛋白酶(MMPs)及其内源性抑制剂(TIMPs)调节。心脏病状态的临床研究和实验模型报告了在衰竭心脏中以及在向衰竭进展的关键中间时间点,MMPs和TIMPs之间平衡的改变。本文综述了最近用于比较健康、代偿和衰竭心脏中ECM、MMP和TIMP谱的临床、遗传和实验方法,并确定了向心力衰竭转变过程中ECM稳态扰动的共同主题。

相似文献

1
Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007.心力衰竭进展过程中的细胞外基质概况。欧洲青年生理学家研讨会主题演讲——2007年布拉迪斯拉发
Acta Physiol (Oxf). 2008 Sep;194(1):3-21. doi: 10.1111/j.1748-1716.2008.01881.x. Epub 2008 Jun 28.
2
Cardiac remodeling and failure From molecules to man (Part II).心脏重塑与衰竭:从分子到人体(第二部分)
Cardiovasc Pathol. 2005 Mar-Apr;14(2):49-60. doi: 10.1016/j.carpath.2005.01.005.
3
Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.组织金属蛋白酶抑制剂(TIMPs)与心力衰竭。
Heart Fail Rev. 2012 Sep;17(4-5):693-706. doi: 10.1007/s10741-011-9266-y.
4
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.心力衰竭进展过程中压力超负荷的人类心肌中的基质金属蛋白酶及其组织抑制剂
J Am Coll Cardiol. 2004 Oct 19;44(8):1609-18. doi: 10.1016/j.jacc.2004.07.023.
5
Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium.心力衰竭中的心肌重塑与基质金属蛋白酶:间质内的紊乱
Ann Med. 2001 Dec;33(9):623-34. doi: 10.3109/07853890109002108.
6
Matrix metalloproteinases: regulation and dysregulation in the failing heart.基质金属蛋白酶:在衰竭心脏中的调节与失调
Circ Res. 2002 Mar 22;90(5):520-30. doi: 10.1161/01.res.0000013290.12884.a3.
7
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats.在高血压大鼠从肥大向心力衰竭转变过程中,基质金属蛋白酶的过度激活与左心室重塑同时发生。
J Am Coll Cardiol. 2002 Apr 17;39(8):1384-91. doi: 10.1016/s0735-1097(02)01756-4.
8
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.基质金属蛋白酶和金属蛋白酶组织抑制剂在左心室舒张功能障碍和射血分数保留心力衰竭的细胞外基质重塑中的作用:系统评价和荟萃分析。
Int J Mol Sci. 2020 Sep 14;21(18):6742. doi: 10.3390/ijms21186742.
9
Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.雌激素可改善超重心脏中 TIMP-MMP 平衡和胶原分布,这种作用在去卵巢雌性动物中更为明显。
Am J Physiol Regul Integr Comp Physiol. 2010 Aug;299(2):R683-93. doi: 10.1152/ajpregu.00162.2010. Epub 2010 May 26.
10
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.TIMPs 与心脏重构:“拥抱 MMP 家族的非依赖性一面”。
J Mol Cell Cardiol. 2010 Mar;48(3):445-53. doi: 10.1016/j.yjmcc.2009.09.013. Epub 2009 Sep 30.

引用本文的文献

1
Remodelling and dysfunction of the sinus node in pulmonary arterial hypertension.肺动脉高压中心房结的重构和功能障碍。
Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220178. doi: 10.1098/rstb.2022.0178. Epub 2023 May 1.
2
Optimizing Anisotropic Polyurethane Scaffolds to Mechanically Match with Native Myocardium.优化各向异性聚氨酯支架以使其机械性能与天然心肌相匹配。
ACS Biomater Sci Eng. 2020 May 11;6(5):2757-2769. doi: 10.1021/acsbiomaterials.9b01860. Epub 2020 Apr 6.
3
The miRNA-184 drives renal fibrosis by targeting HIF1AN in vitro and in vivo.
miRNA-184 通过靶向体内外的 HIF1AN 驱动肾纤维化。
Int Urol Nephrol. 2019 Mar;51(3):543-550. doi: 10.1007/s11255-018-2025-4. Epub 2018 Dec 10.
4
Knockdown of Sestrin2 Increases Lipopolysaccharide-Induced Oxidative Stress, Apoptosis, and Fibrotic Reactions in H9c2 Cells and Heart Tissues of Mice via an AMPK-Dependent Mechanism.敲低 Sestrin2 通过 AMPK 依赖的机制增加脂多糖诱导的 H9c2 细胞和小鼠心脏组织中的氧化应激、细胞凋亡和纤维化反应。
Mediators Inflamm. 2018 Jul 5;2018:6209140. doi: 10.1155/2018/6209140. eCollection 2018.
5
MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.心力衰竭合并慢性肾脏病患者的基质金属蛋白酶-2和金属蛋白酶组织抑制因子-2
Open Med (Wars). 2018 Jun 14;13:237-246. doi: 10.1515/med-2018-0037. eCollection 2018.
6
The expression of matrix metalloproteinases and their inhibitors in corneal fibroblasts by alarmins from necrotic corneal epithelial cells.坏死角膜上皮细胞释放的警报素对角膜成纤维细胞中基质金属蛋白酶及其抑制剂表达的影响
Jpn J Ophthalmol. 2018 Jan;62(1):92-100. doi: 10.1007/s10384-017-0541-x. Epub 2017 Nov 1.
7
The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study.射血分数降低的心力衰竭患者血清纤维化标志物与心室充盈受限的关系:一项锝-99m放射性核素心室造影研究。
Oncotarget. 2017 Jan 10;8(2):2381-2390. doi: 10.18632/oncotarget.13795.
8
Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases.先天性心脏病相关肺动脉高压的血浆蛋白质组学研究
Sci Rep. 2016 Nov 25;6:36541. doi: 10.1038/srep36541.
9
Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.走向心肌梗死后的全面心脏修复与再生:需考虑的方面及待递送的蛋白质
Biomaterials. 2016 Mar;82:94-112. doi: 10.1016/j.biomaterials.2015.12.025. Epub 2015 Dec 29.
10
Sex differences in porcine left ventricular myocardial remodeling due to right ventricular pacing.
Biol Sex Differ. 2015 Dec 10;6:32. doi: 10.1186/s13293-015-0048-4. eCollection 2015.